5
D
:
5
H
:
5
M
:
5
S
from sept 25 to 27, 2024

PROGRAM

wednesday,
september 25

08:00 - 12:00

Preconference: Educational Workshop

+ INFO

12:45 - 13:15

welcome of participants

13:15 - 13:30

opening remarks

13:30 - 14:15

Plenary – Gemma Salvado

(Lund University, Sweden)

Recent Advancements in European Research

+ INFO

14:15 - 15:15

New imaging developements and innovative approaches

Speakers:

  • Meera Srikrishna (Sweden)
  • Heidi Jacobs (The Netherlands)
  • Mitsuko Nakajima (United Kingdom)
  • Joana B. Pereira (Sweden)

15:15 - 15:45

Datablitz

15:45 - 16:45

coffee break – poster session

16:45 - 18:00

ad subtypes and differential diagnosis

Speakers:

  • Jacob Vogel (Sweden)
  • Rik Ossenkoppele (The Netherlands / Sweden)
  • Alexandre Bejanin (Spain)
  • Gérard Bischof (Germany)
  • Michela Pievani (Italy)

19:00

Welcome Reception : Cocktail & Public Event

+ INFO

thursday,
september 26

09:00 - 10:00

Plenary – Jonathan Schott

(UCL, United Kingdom)

Using imaging to detect and understand preclinical dementia: insights from the British 1946 birth cohort

+ INFO

10:00 - 10:20

Coffee Break

10:20 - 11:45

Opportunities and Challenges in Data Sharing in European Neuroimaging

Speakers:

  • Julia Neitzel (The Netherlands)
  • Oliver Speck (Germany)
  • Ludovica Griffanti (United Kingdom)
  • Lyduine Collij (Sweden)
  • Kristine Walhovd (Norway)

Q&A session

11:45 - 12:05

Datablitz

12:05 - 13:05

Lunch

13:05 - 14:20

The present and future of PET imaging

Speakers:

  • Agneta Nordberg (Sweden)
  • Bernard Hanseeuw (Belgium)
  • Maura Malpetti (United Kingdom)
  • Julien Lagarde (France)
  • Ruben Smith (Sweden)

14:20 - 15:20

Coffee Break – Poster Session

15:20 - 16:20

Neuroimaging correlates of biofluids and neuropathology

Speakers:

  • Laura Jonkman (The Netherlands)
  • Valentina Perosa (Germany)
  • Marc Suarez Calvet  (Spain)
  • Alexa Pichet Binette (Sweden)

16:45

Social activity and Gala

Bus leaves at 16h45

+ INFO

friday,
september 27

09:00 - 10:00

Plenary – Renaud La Joie

 (UCSF, United States) 

Neuroimaging in the era of anti-amyloid therapies

+ INFO

10:00 - 10:30

Coffee Break

10:30 - 11:45

Modifiable risk and protective factors and non-pharmacological interventions

Speakers:

  • Federica Agosta (Italy)
  • Emrah Duzel (Germany)
  • Gaël Chételat (France)
  • Simon Cox (Scotland)
  • Eider Arenaza-Urquijo (Spain)

11:45 - 12:15

Awards

12:15 - 12:30

Closing remarks

Plenary Sessions

Gemma Salvado

Post-doctoral researcher at Lund University (Sweden)
+ INFO
Introductive Talk Recent Advancements in European Research

Jonathan Schott

Professor of Neurology, UCL Dementia Research Centre (UK)
+ INFO
Plenary #1 Using imaging to detect and understand preclinical dementia: insights from the British 1946 birth cohort

Renaud La Joie

Assistant Professor, Memory and Aging Center, UCSF (USA)
+ INFO
Plenary #2 Neuroimaging in the era of anti-amyloid therapies

symposium

1. New imaging techniques and innovative approaches

  • #1 Meera Srikrishna
    University of Gothenburg, Sweden
    « CT-based imaging markers for idiopathic normal pressure hydrocephalus obtained using deep learning: association with MRI-based radiological markers and diagnosis » 
  • #2 Heidi Jacobs
    Maastricht University & Massachusetts General Hospital, The Netherlands /USA
    « Locus coeruleus imaging to identify

    pre-preclinical Alzheimer’s disease »
  • #3 Mistuko Nakajima
    University College London, United-Kingdom
    « Differential cortical layer vulnerability in

    premanifest Huntington’s disease »
  • #4 Joana Pereira
    Karolinska Institutet, Sweden
    « Understanding the role of the neuromodulatory nucleiin brain connectivity in aging and neurodegeneration »
+ INFO

2. AD subtypes and differential diagnosis

 

  • #5 Jacob Vogel
    Lund University, Sweden
    « An update on Alzheimer’s disease tau subtypes: clinical and biological insights »
  • #6 Rik Ossenkoppele
    VU Amsterdam & Lund University, The Netherlands/Sweden
    « AT(N) imaging in atypical variants of Alzheimer’s disease »
  • #7 Alexandre Bejanin
    IIB Sant Pau, Spain
    « Neuroimaging of Alzheimer’s and vascular pathologies in Down syndrome »
  • #8 Gérard Bischof
    University Hospital Cologne, Germany
    « 18F-PI2620 Tau PET in AD and Non-AD
    Neurodegenerative Diseases »
  • #9 Michela Pievani
    RCCS Centro San Giovanni di Dio, Italy
    « Brain networks connectivity in AD and FTD »
+ INFO

3. Opportunities and Challenges in Data Sharing in European Neuroimaging

  • #10 Julia Neitzel
    Erasmus MC University Medical Center Rotterdam, The Netherlands
    « Data sharing strategies in the Rotterdam Study »
  • #11 Oliver Speck
    Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
    « Opportunities and Challenges in multicenter

    MR neuroimaging studies »
  • #12 Ludovica Griffanti
    University of Oxford, United Kingdom
    « From ‘big data’ to the clinic: implementing the UK Biobank imaging framework for memory clinic patients »
  • #13 Lyduine Collij
    Amsterdam UMC & Lund University, The Netherlands/Sweden
    « From AMYPAD to EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectorie »
  • #14 Kristine Walhovd
    University of Oslo, Norway
    « Longitudinal neuroimaging studies- Lifebrain and beyond »
+ INFO

4. The present and future of PET imaging

  • #15 Agneta Nordberg
    NVS,Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Sweden
    « PET imaging markers in neurodegenerative diseases – the present and future »
  • #16 Bernard Hanseeuw
    Cliniques Universitaires Saint-Luc, UCLouvain, Belgium / Massachusetts General Hospital, Harvard Medical School, USA
    « Tau-PET imaging: From research data to Appropriate Use Criteria »
  • #17 Maura Malpetti
    Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK
    « PET imaging of synaptic health across
    neurodegenerative diseases »
  • #18 Julien Lagarde
    Hôpital Sainte-Anne, Université Paris-Cité,
    Université Paris-Saclay, France
    « PET imaging of neuroinflammation in AD and potential implications in therapeutic trials »
    #19 Ruben Smith 
    Lund University / Skåne University Hospital, Sweden
    « LAlpha-synuclein PET imaging »
+ INFO

5. Neuroimaging correlates of biofluids and neuropathology

  • #20 Laura Jonkman
    Amsterdam UMC, the Netherlands
    « MRI signatures of neuropathology »
  • #21 Valentina Perosa
    Massachusetts General Hospital, Harvard Medical School, USA
    « Leveraging high-resolution ex vivo neuroimaging to gain insight into the pathophysiology of cerebral small vessel disease »
  • #22 Marc Suárez-Calvet
    Barcelonaβeta Brain Research Center, Spain
    « New plasma biomarkers related to PET imaging »
  • #23 Alexa Pichet Binette
    Lund University, Sweden
    « Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo »
+ INFO

6.  Modifiable risk and protective factors and non-pharmacological interventions

  • #24 Federica Agosta
    Vita-Salute San Raffaele University, Italy
    « Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapies: risk factors, symptomatology and monitoring recommendations »
  • #25 Emrah Düzel
    Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
    « Targeting dysfunction in episodic memory circuitry in Alzheimer’s disease»
  • #26 Gaël Chételat
    Inserm-Université de Caen, France
    « Enhancing Brain Health: The Preventive Potential of Meditation against Neurodegenerative Diseases »
  • #27 Simon Cox
    University of Edinburgh, Scotland
    « Dementia and Cognitive Ageing in the Lothian Birth Cohorts »
  • #28 Eider Arenaza-Urquijo
    Barcelona Institute for Global Health, Spain
    « From the individual to the environment: understanding cognitive and brain resilience in aging »
+ INFO

NEWSLETTER

This website uses cookies to ensure audience measurement, as well as sharing or redirection to social networks. (Know more)
OK